サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566958

動物用歩行補助具市場：製品タイプ別、動物タイプ別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年

Animal Aids Market By Product Type , By Animal Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
動物用歩行補助具市場：製品タイプ別、動物タイプ別、エンドユーザー別：世界の機会分析と産業予測、2024～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用歩行補助具市場は、2023年には9億米ドルと評価され、2024～2033年までCAGR 5.7%で成長し、2033年には15億米ドルに達すると予測されています。

動物用歩行補助具は、動物の幸福のために設計された道具、装置、サービスです。義肢や車椅子のような医療補助器具から、訓練用具やエンリッチメント・トイのような行動補助器具まで様々です。獣医サービスや治療も動物用歩行補助具の対象であり、動物がケアやサポートを受けられるようにすることで、動物福祉を促進します。

動物用歩行補助具の世界市場の成長は、ペット飼育数の増加、動物の福祉に対する社会的認識と関心の高まりによってもたらされます。米国を拠点とするビジネス誌Forbes Advisorの2024年の統計によると、米国では約8,690万世帯がペットを飼っています。ペット飼育の増加に伴い、動物ケア製品やサービスに対する需要も同時に増加し、動物用歩行補助具市場の成長が促進されると予想されます。さらに、ペットの寿命が延び、可処分所得が急増することで、ペットの飼い主はペットの健康と幸福のために多くの出費をするようになり、その結果、医療支援補助器具の販売を後押ししています。さらに、ウェアラブル技術やスマート給餌システムの普及が市場の成長に大きく寄与しています。例えば、GPSトラッカーやヘルスモニターなどのデバイスは、ペットの日々の活動を追跡するために使用されています。さらに、ペットの飼い主は、スマートフォンのアプリで制御できる自動給餌器や給水器にますます注目するようになっており、利便性を提供し、留守中でもペットがスケジュール通りに給餌や水分補給を受けられるようにしています。しかし、高度な動物用歩行補助具と獣医療的治療に関連する高額な費用と、高度な動物用歩行補助具の使用と処方の訓練を受けた獣医専門家の不足が、市場の成長を大幅に抑制しています。逆に、動物の健康と福祉を促進する政府の支援政策は、予測期間中に世界市場の拡大に有利な機会を提供すると期待されています。例えば、世界動物保健機構（WOAH）は、獣医サービスの能力を強化することにより、世界の動物の健康と福祉の向上を目指しています。さらに、ペットの遠隔監視サービスの普及が進むことで、今後数年間で市場成長の新たな道が開けると期待されています。

世界の動物用歩行補助具市場は、製品タイプ、動物タイプ、エンドユーザー、地域に区分されます。製品タイプ別では、医薬品、栄養補助食品、診断用製品、手術用機器、創傷ケア製品に分けられます。動物タイプ別では、コンパニオンアニマル、畜産動物、野生動物に分類されます。エンドユーザー別では、動物病院＆クリニック、動物保護施設＆レスキューセンター、農場＆牧場、ペットオーナーに分類されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主要調査結果

製品タイプ別では、2023年の動物用歩行補助具市場では医薬品セグメントが最大のシェアを占めています。

動物タイプ別では、コンパニオンアニマルセグメントが2023年の主要株主でした。

エンドユーザー別では、動物病院・クリニックセグメントが2023年の市場を独占しました。

地域別では、北米が2023年の主要収益貢献国であり、今後数年間は市場を独占すると予想されます。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 顧客の関心に応じた企業プロファイルの追加

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主要調査結果
    • 主要投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 動物用歩行補助具市場：製品タイプ別

  • 市場概要
  • 医薬品
  • 栄養補助食品
  • 診断用製品
  • 手術機器
  • 創傷ケア製品

第5章 動物用歩行補助具市場：動物タイプ別

  • 市場概要
  • コンパニオンアニマル
  • 家畜動物
  • 野生動物

第6章 動物用歩行補助具市場：エンドユーザー別

  • 市場概要
  • 動物病院・クリニック
  • 動物保護施設とレスキューセンター
  • 農場と牧場
  • ペットオーナー

第7章 動物用歩行補助具市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の動物用歩行補助具市場
    • カナダの動物用歩行補助具市場
    • メキシコの動物用歩行補助具市場
  • 欧州
    • 主要市場動向と機会
    • フランスの動物用歩行補助具市場
    • ドイツの動物用歩行補助具市場
    • イタリアの動物用歩行補助具市場
    • スペインの動物用歩行補助具市場
    • 英国の動物用歩行補助具市場
    • その他の欧州の動物用歩行補助具市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国の動物用歩行補助具市場
    • 日本の動物用歩行補助具市場
    • インドの動物用歩行補助具市場
    • 韓国の動物用歩行補助具市場
    • オーストラリアの動物用歩行補助具市場
    • その他のアジア太平洋の動物用歩行補助具市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの動物用歩行補助具市場
    • 南アフリカの動物用歩行補助具市場
    • サウジアラビアの動物用歩行補助具市場
    • その他のラテンアメリカ・中東・アフリカの動物用歩行補助具市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Zoetis Inc.
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Merck Animal Health
  • Bayer Animal Health
  • CEVA Sante Animale S.A.S.
  • Virbac
  • Vetoquinol
  • Dechra Pharmaceuticals Plc.
  • Phibro Animal Health Corporation.
目次
Product Code: A324362

The animal aids market was valued at $0.9 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Animal aids are tools, devices, and services designed for the well-being of animals. These can range from medical aids like prosthetics and wheelchairs to behavioral aids such as training tools and enrichment toys. Veterinary services and therapeutic treatments are also covered under animal aids, which ensure that animals receive the care and support, thus promoting animal welfare.

The growth of the global animal aids market is driven by rise in pet ownership and increase in public awareness and concern for the well-being of animals. According to the 2024 statistics determined by Forbes Advisor-a U.S.-based business magazine-approximately 86.9 million homes in the U.S. own a pet. With increasing adoption of pets, the demand for animal care products and services is expected to rise simultaneously, thereby fostering the growth of the animal aids market. Furthermore, increase in lifespan of pets and surge in disposable income encourage pet owners to spend more on their pets' health and well-being, thus boosting the sale of medical and supportive aids. Moreover, increase in penetration of wearable technology and smart feeding systems notably contributes toward the growth of the market. For instance, devices such as GPS trackers and health monitors are being used to track the daily activities for pets. In addition, pet owners are increasingly turning to automated feeders and water dispensers that can be controlled via smartphone apps, providing convenience and ensuring their pets are fed and hydrated on schedule even when they are not home. However, high costs associated with advanced animal aids and veterinary treatments and dearth of veterinary professionals trained in using and prescribing advanced animal aids significantly restrain the growth of the market. On the contrary, supportive government policies promoting animal health and welfare are expected to offer lucrative opportunities for the expansion of the global market during the forecast period. For instance, the World Organisation for Animal Health (WOAH) aims to improve global animal health and welfare by enhancing the capacity of veterinary services. Furthermore, increase in penetration of remote monitoring services for pets is expected to open new avenues for the market growth in the coming years.

The global animal aids market is segmented into product type, animal type, end user, and region. On the basis of product type, the market is divided into medicinal products, nutritional supplements, diagnostic products, surgical equipment, and wound care products. By animal type, it is classified into companion animals, livestock animal, and wildlife animal. Depending on end user, it is categorized into veterinary clinics & hospitals, animal shelters & rescue centers, farms & ranches, and pet owners. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product type, the medicinal product segment accounted for the largest share in 2023 in the animal aids market.

Depending on animal type, the companion animal segment was the major shareholder in 2023.

On the basis of end user, the veterinary clinics & hospitals segment dominated the market in 2023.

Region wise, North America was the key revenue contributor in 2023, and is expected to dominate the market in the coming years.

Competition Analysis

Competitive analysis and profiles of the major players in the global animal aids market include Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health, Bayer Animal Health, CEVA Sante Animale S.A.S., Virbac, Vetoquinol, Dechra Pharmaceuticals Plc., and Phibro Animal Health Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Product Type

  • Medicinal Products
  • Nutritional Supplements
  • Diagnostic Products
  • Surgical Equipment
  • Wound Care Products

By Animal Type

  • Companion Animals
  • Livestock Animal
  • Wildlife Animal.

By End User

  • Veterinary Clinics and Hospitals
  • Animal Shelters and Rescue Center
  • Farms and Ranches
  • Pet Owners

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Zoetis Inc.
    • Boehringer Ingelheim Animal Health
    • Elanco Animal Health
    • Merck Animal Health
    • Bayer Animal Health
    • CEVA Sante Animale S.A.S.
    • Virbac
    • Vetoquinol
    • Dechra Pharmaceuticals plc.
    • Phibro Animal Health Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANIMAL AIDS MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Medicinal Products
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Nutritional Supplements
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Diagnostic Products
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Surgical Equipment
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Wound Care Products
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: ANIMAL AIDS MARKET, BY ANIMAL TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Animal Type
  • 5.2. Companion Animals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Livestock Animal
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Wildlife Animal.
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANIMAL AIDS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Veterinary Clinics And Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Animal Shelters And Rescue Center
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Farms And Ranches
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Pet Owners
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: ANIMAL AIDS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product Type
    • 7.2.3. Market Size and Forecast, By Animal Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Animal Aids Market
      • 7.2.6.1. Market Size and Forecast, By Product Type
      • 7.2.6.2. Market Size and Forecast, By Animal Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Animal Aids Market
      • 7.2.7.1. Market Size and Forecast, By Product Type
      • 7.2.7.2. Market Size and Forecast, By Animal Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Animal Aids Market
      • 7.2.8.1. Market Size and Forecast, By Product Type
      • 7.2.8.2. Market Size and Forecast, By Animal Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product Type
    • 7.3.3. Market Size and Forecast, By Animal Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Animal Aids Market
      • 7.3.6.1. Market Size and Forecast, By Product Type
      • 7.3.6.2. Market Size and Forecast, By Animal Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Animal Aids Market
      • 7.3.7.1. Market Size and Forecast, By Product Type
      • 7.3.7.2. Market Size and Forecast, By Animal Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Animal Aids Market
      • 7.3.8.1. Market Size and Forecast, By Product Type
      • 7.3.8.2. Market Size and Forecast, By Animal Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Animal Aids Market
      • 7.3.9.1. Market Size and Forecast, By Product Type
      • 7.3.9.2. Market Size and Forecast, By Animal Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Animal Aids Market
      • 7.3.10.1. Market Size and Forecast, By Product Type
      • 7.3.10.2. Market Size and Forecast, By Animal Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Animal Aids Market
      • 7.3.11.1. Market Size and Forecast, By Product Type
      • 7.3.11.2. Market Size and Forecast, By Animal Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product Type
    • 7.4.3. Market Size and Forecast, By Animal Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Animal Aids Market
      • 7.4.6.1. Market Size and Forecast, By Product Type
      • 7.4.6.2. Market Size and Forecast, By Animal Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Animal Aids Market
      • 7.4.7.1. Market Size and Forecast, By Product Type
      • 7.4.7.2. Market Size and Forecast, By Animal Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Animal Aids Market
      • 7.4.8.1. Market Size and Forecast, By Product Type
      • 7.4.8.2. Market Size and Forecast, By Animal Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Animal Aids Market
      • 7.4.9.1. Market Size and Forecast, By Product Type
      • 7.4.9.2. Market Size and Forecast, By Animal Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Animal Aids Market
      • 7.4.10.1. Market Size and Forecast, By Product Type
      • 7.4.10.2. Market Size and Forecast, By Animal Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Animal Aids Market
      • 7.4.11.1. Market Size and Forecast, By Product Type
      • 7.4.11.2. Market Size and Forecast, By Animal Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product Type
    • 7.5.3. Market Size and Forecast, By Animal Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Animal Aids Market
      • 7.5.6.1. Market Size and Forecast, By Product Type
      • 7.5.6.2. Market Size and Forecast, By Animal Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Animal Aids Market
      • 7.5.7.1. Market Size and Forecast, By Product Type
      • 7.5.7.2. Market Size and Forecast, By Animal Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Animal Aids Market
      • 7.5.8.1. Market Size and Forecast, By Product Type
      • 7.5.8.2. Market Size and Forecast, By Animal Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Animal Aids Market
      • 7.5.9.1. Market Size and Forecast, By Product Type
      • 7.5.9.2. Market Size and Forecast, By Animal Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Zoetis Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Boehringer Ingelheim Animal Health
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Elanco Animal Health
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Merck Animal Health
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Bayer Animal Health
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. CEVA Sante Animale S.A.S.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Virbac
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Vetoquinol
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Dechra Pharmaceuticals Plc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Phibro Animal Health Corporation.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments